Print this page
-
Selecting for Cetuximab Responders in Advanced Head and Neck SCC
Protocol: 031204Principal Investigator:
- Sung Kim M.D (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Eye and Orbit
Lip, Oral Cavity and Pharynx
Esophagus
Larynx
Soft Tissue
Thyroid -
A Phase I Trial of Atezolizumab and Varlilumab in Combination with Radiation in Patients with Metastatic Non-small Cell Lung Cancer (NSCLC)
Protocol: 031912Principal Investigator:
- Jyoti Malhotra MD, MPH (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Lung -
NSABP B-51: A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
NRG Oncology
Protocol: 041308Principal Investigator:
- Bruce Haffty MD (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Breast - Female -
Alliance A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy.
Protocol: 041502Principal Investigator:
- Bruce Haffty MD (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Breast - Female -
11-497: PARTIQoL: Prostate Advanced Radiation Technologies Investigating Quality of Life. A Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer.
Protocol: 081510Principal Investigator:
- Rahul Parikh M.D (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Prostate -
RTOG 3510: Pragmatic Phase III Randomized Trial of Proton vs Photon Therapy for Patients with Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
Protocol: 041511Principal Investigator:
- Bruce Haffty MD (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Breast - Female
Breast - Male
